Membrane Vesicle Formation Due to Acquired Mitoxantrone Resistance in Human Gastric Carcinoma Cell Line EPG85–257

Cancer Research

Volumn 50, Issue 18, 1990, Pages 6100-6106

  Dietel, Manfred ^a   Lage, Hermann ^a   Arps, Hartmut ^b   Niendorf, Axel ^b  

^a UNIVERSITY OF KIEL   (Germany)

^b UNIVERSITY OF HAMBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; COLCHICINE; CYCLOSPORIN A; DACTINOMYCIN; DAUNORUBICIN; DOXORUBICIN; MITOXANTRONE; VERAPAMIL; VINBLASTINE; VINCRISTINE;

ARTICLE; CELL CULTURE; CYTOCHEMISTRY; CYTOLOGY; DRUG RESISTANCE; HUMAN; HUMAN CELL; MEMBRANE VESICLE; PRIORITY JOURNAL; STOMACH CARCINOMA; TUMOR CELL LINE; ULTRASTRUCTURE;

CELL MEMBRANE; DRUG RESISTANCE; HUMAN; MEMBRANE GLYCOPROTEINS; MITOXANTRONE; P-GLYCOPROTEIN; STOMACH NEOPLASMS; SUPPORT, NON-U.S. GOV'T; TUMOR CELLS, CULTURED;

EID: 0025175599     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Goldie, J. H., and Goldman, A. J. The genetic origin of drug resistance in neoplasms: implications for systemic therapy. Cancer Res., 44: 3643–3653, 1984.
2. Pommier, Y., Kerrigan, D., Schwartz, R. E., Swack, J. A., and McCurdy, A. Altered DNA topoisomerase II activity in Chinese hamster cells resistant to topoisomerase II inhibitors. Cancer Res., 46: 3075–3081, 1986.
3. Batist, G., Tulpule, A., Sinha, B. K., et al. Overexpression of a novel anionic glutathione transferase in multidrug-resistant human breast cancer cells. J. Biol. Chem., 261: 15544–15549, 1986.
4. Kodate, C., Fukushi, A., Narita, T., et al. Human placental form of glutathi-one-S-transferase (GST) as a new immunohistochemical marker for human colonic carcinoma. Jpn. J. Cancer Res., 77: 226–229, 1986.
5. Kleinberger, T., Etkin, S., and Lavi, S. Carcinogen-mediated methotrexate resistance and dihydrofolate reductase amplification in Chinese hamster cells. Mol. Cell. Biol., 6: 1958–1964, 1986.
6. Dean, S. W., Gibson, N. W., and Tew, K. D. Selection of nitrogen mustard resistance in a rat tumor cell line results in loss of guanine-06-alkyl transferase activity. Mol. Pharmacol., 30: 77–80, 1986.
7. Anderson, R. E., Standefer, J. C., Truop, G. M., and Pogue, L. E. Partial characterization of a mitomycin-C resistant T cell. J. Leukocyte Biol., 41: 39–44, 1987.
8. Seeber, S., Osieka, R., Schmidt, C. G., Achterrath, W., and Crooke, S. T. In vivo resistance toward anthracyclines, etoposide and cis-diamminedichloro-platinum (II). Cancer Res., 42:4719–4725, 1982.
9. Glisson, B., Gupta R., Hodges P., and Ross, W. Cross-resistance to intercalating agents in an epipodophyllotoxin-resistant Chinese hamster ovary cell line: evidence for a common intracellular target. Cancer Res., 46: 1939–1942, 1986.
10. Teicher, B. A., Holden, S. A., Kelley, M. A., Shea, T. C., Cucchi, C. A., Rosowsky, A., Henner, W. D., and Frei, E. Characterization of a human squamous carcinoma cell line resistant to cis-diamminedichloroplatinum (II) 1. Cancer Res., 47: 388–393, 1987.
11. Ling, V. Genetic basis of drug resistance in mammalian cells. In: N. Bru-chovsky and J. H. Goldie (eds.). Drug and Hormone Resistance in Neoplasia, Vol. 1, pp. 1–19. Boca Raton, FL: CRC Press Inc., 1982.
12. Borst, P. DNA amplification, multidrug resistance and cancer chemotherapy. Nature (Lond.), 309: 580, 1984.
13. Gros, P., Croop, J., Roninson, I., Varshavsky, A., and Housman, D. E. Isolation and characterization of DNA sequences amplified in multidrug-resistant hamster cells. Proc. Natl. Acad. Sci. USA, 83: 337–341, 1986.
14. Gros,P., Neriah, Y. B., Croop, L. M., and Housman, D. E. Isolation and expression of a complementary DNA that confers multidrug resistance. Nature (Lond.), 323: 728–731, 1986.
15. Roninson, I. B., Chin, J. E., Choi, K., Gros, P., Housman D. E., Fojo, A., Shen D.-W., Gottesman, M. M., and Pastan, I. Isolation of human mdr DNA sequences amplified in multidrug-resistant KB carcinoma cells. Proc. Natl. Acad. Sci. USA, 83:4538–4542, 1986.
16. Teeter, L. D., Sanford, J. A., Sen, S., Stallings, R. L., Siciliano, M. J., and Kuo, M. T. Multidrug-resistant phenotype cosegregates with an amplified gene in somatic hybrids of drug-resistant Chinese hamster ovary cells and drug-sensitive murine cells. Mol. Cell. Biol., 6:4268–4273, 1986.
17. Bliek van der, A. M., Velde-Koerts van der, T., Ling, V., and Borst, P. Overexpression and amplification of five genes in a multidrug-resistant Chinese hamster ovary cell line. Mol. Cell. Biol., 6:1671–1678, 1986.
18. Fojo, A. T., Ueda, K., Slamon, D. J., Poplacl, D. G., Gottesman, M. M., and Pastan, I. Expression of a multidrug-resistance gene in human tumors and tissues. Proc. Natl. Acad. Sci. USA, 84: 265–269, 1987.
19. Riordan, J. R., and Ling, V. Purification of P-glycoprotein from plasma membrane vesicles of Chinese hamster ovary cell mutants with reduced colchicine permeability. J. Biol. Chem., 254: 12701–12705, 1979.
20. Richert, N., Akiyama S.-I., Shen, D.-W., Gottesman, M. M., and Pastan, I. Multiply drug-resistant human KB carcinoma cells have decreased amounts of a 75-KDa and a 72-KDa glycoprotein. Proc. Natl. Acad. Sci. USA, 82: 2330–2333, 1985.
21. Meyers, M. B., Spengler, B. A., Chang, T.-D., Melera, P. W., and Biedler, J. L. Gene amplification-associated cytogenetic aberrations and protein changes in vincristine-resistant Chinese hamster, mouse, and human cells. J. Cell. Biol., 100: 588–596, 1985.
22. Shen, D. W., Cardarelli, C., Hwang, J., Cornwell M., Richert, N., Ishii, S., Pastan, I., and Gottesman, M. M. Multiple drug-resistant human KB carcinoma cells independently selected for high-level resistance to colchicine. Adriamycin or vinblastine show changes in expression of specific proteins. J. Biol. Chem., 261:7762–7770, 1986.
23. Fojo, A., Akiyama, S.-I., Gottesman, M. M., and Pastan, I. Reduced drug accumulation in multiply drug-resistant human KB carcinoma cell lines. Cancer Res., 45:3002–3007, 1985.
24. Goldenberg, G. J., Wang, H., and Blair, G. W. Resistance to Adriamycin: relationship of cytotoxicity to drug uptake and DNA single- and double-strand breakage in cloned cell lines of Adriamycin-sensitive and -resistant P388 Leukemia. Cancer Res., 46: 2978–2983, 1986.
25. Carlsen, S. A., Till, J. E., and Ling, V. Modulation of membrane drug permeability in Chinese hamster ovary cells. Biochim. Biophys. Acta, 455: 900–912, 1986.
26. Skovsgaard, T. Mechanisms of cross-resistance between vincristine and dau-norubicin in Ehrlich ascites tumor cells. Cancer Res., 38:4722–4727, 1978.
27. Inaba, M., Fujikura, R., and Sakurai, Y. Active efflux common to vincristine and daunorubicin in vincristine-resistant P388 leukemia. Biochem. Pharmacol., 30:1863–1865, 1981.
28. Willingham, M. C., Cornwell, M. M., Cardarelli C. O., Gottesman, M. M., and Pastan, I. Single cell analysis of daunomycin uptake and efflux in multidrug-resistant and -sensitive KB cells: effects of verapamil and other drugs. Cancer Res., 46: 5941–5946, 1986.
29. Hamada, H., and Tsuruo, T. Functional role for the 170- to 180-kDa glycoprotein specific to drug-resistant tumor cells as revealed by monoclonal antibodies. Proc. Natl. Acad. Sci. USA, 83:7785–7789, 1986.
30. Sehested, M., Skovsgaard, T., van Deurs B., and Winther-Nielsen, H. Increase in nonspecific adsorptive endocytosis in anthracycline- and Vinca alkaloid-resistant Ehrlich ascites tumor cell lines. J. Natl. Cancer Inst., 78: 171–179, 1987.
31. Sehested, M., Skovsgaard, T., van Deurs, B., and Winther-Nielsen, H. Increased plasma membrane traffic in daunorubicin resistant P388 leukaemic cells. Effect of daunorvbicin and verapamil. Br. J. Cancer, 56: 747–751, 1987.
32. Dietel, M., Arps, H., Gerding, D., Trapp, M., and Niendorf, A. Establishment of primary cell cultures: experiences with 155 cell strains. Klin. Wochenschr., 55:507–512, 1987.
33. Dietel, M., Arps, H., Gerding, D., Trapp, M., Sieck, M., and Niendorf, A. Effectiveness of mitoxantrone on the proliferation of cell cultures derived from malignant mesenchymal tumors of human origin. J. Cancer Res. Clin. Oncol., 114:197–203, 1988.
34. Arps, H., Sablotny, B., Dietel, M., Niendorf, A., and Schroder, S. DNA cytophotometry in malignant thyroid tumors- use of different evaluation schemes for prognostic statements. Virchows Arch. A Pathol. Anat., 413: 319–323, 1988.
35. Dietel, M., Arps, H., Klapdor, R., Muller-Hagen, S., Sieck, M., and Hoffmann, L. Antigen detection by the monoclonal antibodies CA 19–9 and CA 125 in normal and tumor tissue and patients’ sera. Cancer Res. Clin. Oncol., 111: 257, 1986.
36. Kartner, N., Evernden-Porelle, D., Bradley, G., and Ling, V. Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodies. Nature (Lond.), 316:820, 1985.
37. Scheper, R. J., Bulte, J. W. M., Brakkee, J. G. P., Quak, J. J., van der Schoot, E., Balm, A. J. M., Meijer, C. J. L. M., Broxterman, H. J., Kuiper, C. M., Lankelma, J., and Pinedo, H. M. Monoclonal antibody JSB-1 detects a highly conserved epitope on the P-glycoprotein associated with multidrug-resistance. Int. J. Cancer, 42: 389–394, 1988.
38. Sugawara, I., Nakahama, M., Hamada, H., Tsuruo, T., and Mori, S. Apparent stronger expression in the human adrenal cortex than in the human adrenal medulla of Mt 170,000–180,000 P-glycoprotein. Cancer Res., 48: 4611–4614, 1988.
39. Chirgwin, J. M., Przybyla, A. E., MacDonald, R. J., and Rutter, W. J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry, 18: 5294–5299, 1979.
40. Maniatis, T., Fritsch, E. F., and Sambrook, J. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1982.
41. Riordan, J. R., Deuchars, K., Karnter, N., Alon, N., Trent, J., and Ling, V. Amplification of P-glycoprotein genes in multidrug-resistant mammalian cell lines. Nature (Lond.), 316:817–819, 1985.
42. Feinberg, A. P., and Vogelstein, B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem., 757:266–267, 1984.
43. Biedler, J., and Riehm, H. Cellular resistance to actinomycin D in Chinese hamster cells in vitro: cross-resistance, radioautographic, and cytogenetic studies. Cancer Res., 30:1174–1184, 1970.
44. Kuo, T. S., Pathak, L., Ramagli, L., Rodriguez, L., and Hsu, T. C. Vincristine-resistant Chinese hamster ovary cells. In: T. Schimke (ed.), Gene Amplification, pp. 53–57. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1982.
45. Akiyama, S., Fojo, J. A., Hanover, J. A., Pastan, I., and Gottesman, M. M. Isolation and genetic characterization of human KB cell lines resistant to multiple drugs. Somat. Cell Mol. Genet., 11:117–126, 1985.
46. Riordan, J. R., and Ling, V. Genetic and biochemical characterization of multidrug resistance. Pharmacol. Ther., 28: 51–75, 1985.
47. Cornwell, M. M., Gottesman, M. M., and Pastan, L.L. Increased vinblastine binding to membrane vesicles from multidrug-resistant KB cells. J. Biol. Chem., 261:7921–7928, 1986.
48. Cornwell, M. M., Pastan, I., and Gottesman M. M. Certain calcium channel blockers bind specifically to multidrug-resistant human KB carcinoma membrane vesicles and inhibit drug binding to P-glycoprotein. J. Biol. Chem., 262:2166–2170, 1987.
49. Beck, W. T., Cirtain, M. C., Danks, M. K., Felsted, R. L., Safa, A. R., Wolverton, J. S., Suttle, D. P., and Trent, J. M. Pharmacological, molecular, and cytogenetic analysis of “atypical“ multidrug-resistant human leukemic cells. Cancer Res., 47: 5455–5460, 1987.
50. Danks, M. K., Yalowich, J. C., and Beck, W. T. Atypical multiple drug resistance in a human leukemic cell line selected for resistance to teniposide (VM-26). Cancer Res., 47:1297–1301, 1987.
51. Harker, W. G., Slade, D. L. Dalton, W. S., Meltzer, P. S., and Trent, J. M. Multidrug resistance in mitoxantrone-selected HL-60 leukemia cells in the absence of P-glycoprotein overexpression. Cancer Res., 49:4542–4549, 1989.
52. Wallace, R. E., Lindh, D., and Durr, F. E. Development of resistance and characteristics of a human colon carcinoma subline resistant to mitoxantrone in vitro. Cancer Invest., 5:417–428, 1987.
53. Dalton, W. S., Cress, A. E., Alberts, D. S., and Trent, J. M. Cytogenetic and phenotypic analysis of a human colon carcinoma cell line resistant to mitoxantrone. Cancer Res., 48: 1882–1888, 1988.
54. Pastan, I., and Willingham, M. C. Journey to the center of the cell: role of the receptorsome. Science (Washington, DC), 214: 504–509, 1981.
55. Dietel, M. What's new in receptor mediated growth promotion of normal and malignant cells? Pathol. Res. Pract., 182:431–442, 1987.
56. Courtoy, P. J., Quintart J., Limet, J. N., De Roe, C., and Baudhuin, P. Polymeric IgA and galactose specific pathways in rat hepatocytes: evidence for intracellular ligand sorting. In: Pastan, I., and Willingham, M. C. (eds.), Endocytosis, pp. 163–184. New York: Plenum Publishing. Corp., 1985.
57. Riehm, H., and Biedler, J. L. Cellular resistance to daunomycin in Chinese hamster cells in vitro. Cancer Res., 31:409–412, 1971.
58. Cornwell, M. M., Safa, A. R., Felsted, R. L., Gottesman, M. M., and Pastan, I. Membrane vesicles from multidrug-resistant human cancer cells contain a specific 150- to 170-kDa protein detected by photoaffinity labeling. Proc. Natl. Acad. Sci. USA, 83: 3847–3850, 1986.
59. Schnipper, L. E. Clinical implications of tumor-cell heterogeneity. N. Engl. J. Med., 314: 1423–1431, 1986.